Prospective Evaluation of the Efficacy and Safety of Zortress (Everolimus)/Myfortic (Enteric Coated Mycophenolate Sodium) Conversion in High MELD Liver Transplantation
Status: Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 23 Oct 2019
Price : $35 *
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate sodium; Tacrolimus
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 23 Oct 2019 Status changed to withdrawn prior to enrolment.
- 07 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 May 2015 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov